This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Bioprocessing & Manufacturing
search
Standardisation

Advancing the Microbiome Therapeutics Industry

Posted by on 14 September 2020
Share this article

The microbiome therapeutics field still has a journey ahead before delivering a globally approved product. What more can be done to further prepare the biopharmaceutical industry and clinical understanding for production of microbiome-based therapies?

This exclusive Microbiome Therapeutics eBook reviews the story so far, the biggest challenges that the industry is yet to overcome, and the most urgent opportunities for innovation. It presents an overview of the existing regulatory landscape, lessons learned in standardizing manufacturing, and the current demands for technologies in research and development.

The ebook includes:

  • The Regulatory Environment of Microbiome-Based Therapies in the US & EU
  • Where Are the Biggest Gaps with Current Technologies to Understand Complex Interactions?
  • Standardization and Opportunities in Manufacturing Microbiome Therapeutics
  • Are Standards for Manufacturing Microbiome Therapeutics Really Far Off?

Click the image at the top of the page or here to explore the ebook.

Share this article